Although today’s market selloff has been disappointing, every cloud has a silver lining.
The silver lining on today’s selloff is that it has pulled down some quality ASX shares to attractive levels.
Two beaten down ASX 200 shares that I would buy are listed below. Here’s why I think today’s selloff has created a buying opportunity:
Appen Ltd (ASX: APX)
The Appen share price ended the day 7% lower on Friday. This latest decline means that the shares of the leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI) markets are now down 25% from their 52-week high. And while this still means they trade at a premium of 37x estimated FY 2021 earnings, I believe this is great value given its very positive long term growth prospects.
This is because spending on machine learning and AI is expected to grow materially over the next decade. I believe this puts Appen in a perfect position to grow its earnings at a strong rate during the 2020s. Overall, I feel this could make Appen shares market-beaters over the long term.
CSL Limited (ASX: CSL)
The CSL share price was out of form and tumbled 4% lower to $279.05 on Friday. As a result, the biopharmaceutical company’s shares are now trading approximately 19% below their 52-week high. I think this is a buying opportunity for investors that are looking for long term investment options.
I believe CSL is one of the most outstanding shares on the Australian share market and capable of growing its earnings at a solid rate over the next decade. Especially given the quality of its therapies and vaccines, its growing plasma collection network, and its lucrative R&D pipeline. The latter has therapies under development which have the potential to generate billions of dollars in sales in the future if they make it to market.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- I love volatile ASX share market days like today
- Why the Transurban share price is outperforming today
- Why Appen, Kogan, OZ Minerals, & ResMed shares are dropping lower
- ASX 200 down 2.75%: Afterpay & Appen sink lower, SKYCITY pushes higher
- Why the Afterpay share price crashed 9% lower today
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Buy these beaten down ASX 200 shares after the market selloff appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2F0GFx1
Leave a Reply